Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot synthesis of naphthoquinone derivatives for anticancer and fluorescent applications. Efficient catalytic route reduces steps and cost.
Patent CN116396189B details a novel boron-catalyzed route for high-purity chiral intermediates, offering significant supply chain stability and cost optimization for global pharmaceutical manufacturers.
Patent CN113307780B details a green synthesis of 2-amino-1,3,4-oxadiazoles using KHSO4. This report analyzes cost reduction and scalability for pharmaceutical intermediate suppliers.
Patent CN119019268A details a safer Lewis acid-catalyzed route for olaflur production, offering significant cost reduction in personal care manufacturing and enhanced supply reliability.
Patent CN103880755A reveals a green catalytic route for 2,4,5-triaryl imidazoles using a biodegradable Brönsted acid, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106554265A reveals a one-step Lewis acid catalyzed route for 1-benzosuberones offering high purity and simplified manufacturing for global pharmaceutical supply chains.
Novel acid-catalyzed route eliminates transition metals ensuring high purity pharmaceutical intermediates. Significant cost reduction and supply chain reliability for global procurement teams seeking scalable solutions.
Patent CN114560894B reveals a novel two-step route to Molnupiravir using Lewis acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN105330547A details a green solid acid catalytic route for methyl benzoylformate. This method offers high purity, recyclable catalysts, and significant supply chain cost reduction advantages.
Patent CN113896645B enables clean synthesis of D-p-HPG. Reduces waste and improves yield for reliable pharmaceutical intermediates supply chains.
Patent CN110407739B details a high-yield, one-pot synthesis of diaryl-tetrahydropyridines. This method offers 100% atom economy and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN110330460B details a high-yield solid acid catalyzed route for p-hydroxyphenylhydantoin, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed method offers high yield and enantioselectivity for chiral intermediates. Reduces costs and simplifies supply chain for pharmaceutical manufacturing partners globally.
Patent CN102898342A details a novel chiral hydroxyl amide synthesis offering 99% conversion in catalysis. Discover cost-effective manufacturing and supply advantages.
Novel preparation method of Bosutinib avoiding hazardous chlorinating agents. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Discover the novel B(C6F5)3 catalyzed synthesis of 2,4,6-triaryl pyridines. A cost-effective, scalable solution for high-purity pharmaceutical and agrochemical intermediates.
Novel green method for delta-cyclopentanolide production using recyclable amino acid ionic liquids, offering cost reduction and high purity for pharma intermediates.
Patent CN116003312B reveals a metal-free boron catalysis method for meta-selective pyridine functionalization, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel BF3-catalyzed route offers high yields and metal-free purification for scalable API intermediate production.
Novel aqueous synthesis of diazinium derivatives using phosphotungstic acid. Offers high yield, mild conditions, and cost reduction in API manufacturing for global supply chains.